)
)
Imunon Investor Relations Material
Latest events
Q3 2024
Imunon
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Imunon Inc
Access all reports
Imunon Inc., formerly Celsion Corporation, a clinical stage biotechnology company, focuses on the development of novel theragnostic technologies for cancer, including the use of radiolabeled DNA plasmids to treat cancer. Celsion has developed, among other, ThermoDox, a DNA plasmid with its proprietary heat-activated liposomal delivery technology, which is designed to improve the effectiveness of cancer immunotherapies such as vaccines and adoptive cell therapies. The company's customers are pharmaceutical and biotechnology companies, research institutions, hospitals and clinics.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
IMNN
Country
🇺🇸 United States